Prosecution Insights
Last updated: November 04, 2026
Application No. 18/443,795

MEDICATION ADHERENCE PLATFORM FOR MEDICATION DETECTION AND DISCERNMENT

Non-Final OA §101§112
Filed
Feb 16, 2024
Examiner
KHATTAR, RAJESH
Art Unit
3684
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Medisensor Technologies Inc.
OA Round
3 (Non-Final)
37%
Grant Probability
At Risk
3-4
OA Rounds
1y 7m
Est. Remaining
73%
With Interview

Examiner Intelligence

Grants only 37% of cases
37%
Career Allowance Rate
208 granted / 566 resolved
-15.3% vs TC avg
Strong +36% interview lift
Without
With
+35.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
24 currently pending
Career history
609
Total Applications
across all art units

Statute-Specific Performance

§101
41.5%
+1.5% vs TC avg
§103
35.8%
-4.2% vs TC avg
§102
3.2%
-36.8% vs TC avg
§112
14.4%
-25.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 566 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant filed a response dated 5/27/2026 in which claims 1-3, 5-6, 11-12, 14-15, 17-19, 21-23, and 25 have been amended, claims 4, 7-10, 16, and 20 have been canceled. Thus, the claims 1-3, 5-6, 11-15, 17-19, and 21-25 are pending in the application. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 5/27/2026 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-3, 5-6, 11-15, 17-19, and 21-25 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 1 (and elsewhere, where applicable), line 6, it is unclear if the batch of samples and the sensed load data refers to pill case and the weight of pills contained in the pill case. In line 7, the scope of “other” as in “other accumulated batch weights” is unclear. What is a detection threshold. Accumulate the batch weight with other accumulated batch weights if the batch weight meets a detection threshold. Not clear why and when to accumulate the batch weight(s). Why meeting a detection threshold is necessary for adding the batch weight(s) together. Lines 9-10, the scope of adapt a tare weight based on the batch weight if it does not meet detection threshold. In lines 11-15, the scope of settled weight as it relates to accumulated batch weight settles or does not settle is unclear? In lines 16-17, does the container weight refers to empty container? This renders the claim indefinite. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-3, 5-6, 11-15, 17-19, and 21-24 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea of determining specified quantities of multiple pill types based on their weights without significantly more. Examiner has identified claim 1 as the claim that represents the claimed invention presented in independent claims 1 and 18. Claim 1 is directed to a system, which is one of the statutory categories of invention (Step 1: YES). The claim 1 is directed to a system, comprising: a host device; and a patient pill case platform comparing a pill case container, a load cell configured to output sensed load data based on a weight of the pill case container, and circuitry configured to: compute a batch weight based on a batch of samples of the sensed load data; accumulate the batch weight with other accumulated batch weights if the batch weight meets a detection threshold; adapt a tare weight based on the batch weight if the batch weight does not meet the detection threshold; compute a settled weight based on the accumulated batch weight if the accumulated batch weight settles; discard the batch weight and the other accumulated batch weights and set a tare weight to a saved tare weight, if the accumulated batch weight does not settle; compute a container weight based on a difference between the settled weight and a tare weight; communicate the container weight based on a difference between the settled weight and a tare weight; communicate the container weight to the host device as a weight detection event; and save the tare weight as a saved tare weight and set the tare weight to the settled weight subsequent to the computation of the container weight; wherein the host device comprises a host processor and memory comprising instructions to cause the host processor to: communicate with the patient pill case platform, a communication device of a patient, and a database of pill weights via respective communication channels; provide instructions to the communication device of the patient for loading a specified quantity of each of multiple pill types into the pill case containers based on a patient medication schedule; receive the weight detection event from the pill case platform subsequent to providing the instructions to the communication device of the patient; compute a statistic for each of the multiple pill types of the patient medication schedule for which the database of pill weights includes multiple pill weights, wherein the statistic comprises one or more of a median and a standard deviation of the multiple pill weights; compute an expected container weight based on the specified quantities of the multiple pill types, weights of the multiple pill types from the database, and the statistic; determine that the pill case container contains the specified quantity of each of the multiple pill types if the container weight of the weight detection event matches the expected container weight within a statistical measure of certainty; compute alternative expected container weights based on various quantities of various combinations of the multiple pill types of the patient medication schedule and the corresponding pill weights of the database, if the container weight of the weight detection event does not match the expected container weight within the statistical measure of certainty; determine that the pill case container contains an incorrect quantity of one or more of the multiple pill types if the container weight of the weight detection event matches one of the alternative expected weights within the statistical measure of certainty; and determine that the pill case container contains an incorrect pill type if the container weight of the weight detection event does not match any of the alternative expected container weights within the statistical measure of certainty. These limitations (with the exception of italicized limitations) describe the abstract idea of determining specified quantities of multiple pill types based on their weights, which correspond to a certain methods of organizing human activity. The additional elements of a host device/processor, a pill case platform/container, a load cell, circuitry, memory, a communication device, and a database do not restrict the claim from reciting an abstract idea. Thus, the claim 1 recites an abstract idea (Step 2A, Prong One: YES). This judicial exception is not integrated into a practical application because the additional elements of a host device/processor, a pill case platform/container, a load cell, circuitry, memory, a communication device, and a database result in no more than simply applying the abstract idea using generic computer elements. The additional elements of a host device/processor, a pill case platform/container, a load cell, circuitry, memory, a communication device, and a database are recited at a high level of generality and under their broadest reasonable interpretation comprises a generic computer arrangement. The presence of a generic computer arrangement is nothing more than to implement the claimed invention by applying the exception using a generic computer element (MPEP 2106.05(f)). Therefore, the recitations of additional elements do not meaningfully apply the abstract idea and hence does not integrate the abstract idea into a practical application. Thus, the claim 1 is directed to an abstract idea (Step 2A-Prong 2: NO). The claim 1 does not include additional elements that are sufficient to amount to significantly more than the judicial exception because the claim recites the additional elements of a host device/processor, a pill case platform/container, a load cell, circuitry, memory, a communication device, and a database are recited at a high level of generality in that it result in no more than simply applying the abstract idea using generic computer elements. The additional elements when considered separately and as an ordered combination do not amount to add significantly more as these elements provide nothing more than to simply apply the exception in a generic computer environment (Step 2B: NO). Thus, the claim 1 is not patent eligible. Similar arguments can be presented for other independent claim 18 and hence the claim 18 is rejected on similar grounds as claim 1. Dependent claims 2-3, 5-6, 11-15, 17, 19, and 21-24 further define the abstract idea that is present in their respective independent claims 1 and 18, thus correspond to a certain methods of organizing human activity, and hence are abstract in nature for the reason presented above. Dependent claims do not include any additional elements that integrate the abstract idea into a practical application or are sufficient to amount to significantly more than the judicial exception when considered both individually and as an ordered combination. Therefore, the claims 1-3, 5-6, 11-15, 17-19, and 21-24 are not patent-eligible. Claim 25 is rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea of computation of the container weight without significantly more. Claim 25 is directed to an apparatus (i.e., an apparatus), which is one of the statutory categories of invention (Step 1: YES). The claim 25 is directed to an apparatus, comprising: a patient pill case platform comprising a pill case container, a load cell configured to output sensed load data based on a weigh of the pill case container, and circuitry configured to: compute a batch weight based on a batch of samples of the sensed load data; accumulate the batch weight with other accumulated batch weights if the batch weight meets a detection threshold; adapt a tare weight based on the batch weight if the batch weight does not meet the detection threshold; compute a settled weight based on the accumulated batch weight if the accumulated batch weight settles; discard the batch weight and the other accumulated batch weights and set a tare weight to a saved tare weight, if the accumulated batch weight does not settle; compute a container weight based on a difference between the settled weight and a tare weight; communicate the container weight to a host device as a weight detection event; and save the tare weight as a saved tare weight and set the tare weight to the settle weight subsequent to the computation of the container weight. These limitations (with the exception of italicized limitations) describe the abstract idea of computation of the container weight, which corresponds to a certain methods of organizing human activity. The additional elements of a patient pill case platform, pill case containers, load cell, circuitry, and a host device do not restrict the claim from reciting an abstract idea. Thus, the claim 25 recites an abstract idea (Step 2A, Prong One: YES). This judicial exception is not integrated into a practical application because the additional elements of a patient pill case platform, pill case containers, load cell, circuitry, and a host device result in no more than simply applying the abstract idea using generic computer elements. The additional elements of a patient pill case platform, pill case containers, load cell, circuitry, and a host device are recited at a high level of generality and under their broadest reasonable interpretation comprises a generic computer arrangement. The presence of a generic computer arrangement is nothing more than to implement the claimed invention by applying the exception using a generic computer element (MPEP 2106.05(f)). Therefore, the recitations of additional elements do not meaningfully apply the abstract idea and hence does not integrate the abstract idea into a practical application. Thus, the claim 25 is directed to an abstract idea (Step 2A-Prong 2: NO). The claim 25 does not include additional elements that are sufficient to amount to significantly more than the judicial exception because the claim recites the additional elements of a patient pill case platform, pill case containers, load cell, circuitry, and a host device are recited at a high level of generality in that it result in no more than simply applying the abstract idea using generic computer elements. The additional elements when considered separately and as an ordered combination do not amount to add significantly more as these elements provide nothing more than to simply apply the exception in a generic computer environment (Step 2B: NO). Thus, the claim 25 is not patent eligible. Response to Arguments Examiner withdraws 35 U.S.C 103 rejection of claims 1-3, 5, 7-10, 12-15, 17-18, and 21-24 in view of the amendment/argument. Applicant's arguments filed dated 5/27/2026 have been fully considered but they are not persuasive due to the following reasons: With respect to the rejection of claims 1-3, 5, 6, 11-15, 17-19, and 21-25 under 35 U.S.C. 101, Applicant states that each of amended independent claims 1, 18, and 25 recite significantly more than an abstract idea. Each of dependent claims 2, 3, 5, 6, 11-15, 17, 19, 22, and 23, and 24 thus overcome the rejection for reasons provided above with respect to amended independent claims 1 and 18. Examiner respectfully disagrees and notes that Applicant does not present any specific argument and concludes that the amended claims recite significantly more than an abstract idea. There is no technical improvement or identification of an inventive concept. The additional elements are recited at a high level of generality in that it simply applies the abstract idea without amounting to add significantly more. Thus, these arguments are not persuasive. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to RAJESH KHATTAR whose telephone number is (571)272-7981. The examiner can normally be reached M-F 8AM-5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Shahid Merchant can be reached at 571-270-1360. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. RAJESH KHATTAR Primary Examiner Art Unit 3684 /RAJESH KHATTAR/Primary Examiner, Art Unit 3684
Read full office action

Prosecution Timeline

Show 1 earlier event
Jun 13, 2025
Non-Final Rejection mailed — §101, §112
Oct 10, 2025
Applicant Interview (Telephonic)
Oct 30, 2025
Examiner Interview Summary
Nov 07, 2025
Response Filed
Jan 27, 2026
Final Rejection mailed — §101, §112
May 27, 2026
Request for Continued Examination
May 28, 2026
Response after Non-Final Action
Aug 19, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12784892
BRAIN STATE RULE GENERATION AND SCORING SYSTEM AND METHOD
3y 6m to grant Granted Nov 03, 2026
Patent 12731677
POINT-OF-CARE MEDICAL ANALYZER CONSUMABLE AVAILABILITY PREDICTION
5y 10m to grant Granted Sep 08, 2026
Patent 12603160
SYSTEM AND METHOD FOR ASSESSING IMMUNE STATUS RELATED TO TRANSMISSIBLE INFECTIOUS DISEASES FOR MITIGATING AGAINST TRANSMISSION
4y 4m to grant Granted Apr 14, 2026
Patent 12567505
SYSTEM THAT SELECTS AN OPTIMAL MODEL COMBINATION TO PREDICT PATIENT RISKS
4y 0m to grant Granted Mar 03, 2026
Patent 12551312
Autonomous Adaptation of Surgical Device Control Algorithm
3y 9m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
37%
Grant Probability
73%
With Interview (+35.9%)
4y 3m (~1y 7m remaining)
Median Time to Grant
High
PTA Risk
Based on 566 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month